已收录 268921 条政策
 政策提纲
  • 暂无提纲
Effects of Eptazocine, a Novel Analgesic, on KCN-Induced Changes in the Cerebral Contents of Glycolytic Metabolites and High-Energy Phosphates in Mice
[摘要] References(27)Cited-By(1)Effects of eptazocine on cerebral metabolic changes due to a sublethal dose of KCN were investigated in mice. KCN (2 mg/kg, i.v.) induced a temporary loss of consciousness being moderated by eptazocine (1-10 mg/kg) in a dosedependent manner. The KCN injection decreased the contents of phosphocreatine (PCr), ATP and glucose and increased the contents of AMP and lactate, resulting in a 34% decrease in energy charge potential (ECP) and an increase in lactate/ pyruvate (L/P) ratio. Such changes were improved by eptazocine (10 mg/kg) and EKC (3 mg/kg), but not by pentazocine (10 mg/kg) and morphine (3 mg/kg), and the improving effect of eptazocine was completely inhibited by MR-2266 (3 mg/kg), a relatively selective opioid κ-receptor antagonist. On the other hand, eptazocine (3, 10 mg/kg) was found to increase the glucose content in normal mice, but not to give significant changes in the contents of glycolytic metabolites and high-energy phosphates. These results suggest that eptazocine may improve anoxic changes in cerebral energy metabolism.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文